Takeda Pharmaceutical Co Adr (TAK)

01:26 AM

Takeda Exits Dementia Drug Partnership With Denali Therapeutics - Benzinga

01:26 AM

Apr 05, 2026

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history - Yahoo Finance Singapore

Apr 05, 2026

Apr 05, 2026

Takeda Pharmaceutical Company Limited (TAK) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 05, 2026

Apr 03, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA) Stock HoldersInstitutional & Insider Ownership - GuruFocus

Apr 03, 2026

Apr 02, 2026

TAK Stock Price, Quote & Chart | TAKEDA PHARMACEUTIC-SP ADR (NYSE:TAK) - ChartMill

Apr 02, 2026

Mar 30, 2026

Takeda Pharmaceutical (ADR) Stock: A Stable Global Pharma Play with Focus on Oncology and Rare Disea - AD HOC NEWS

Mar 30, 2026

Mar 29, 2026

Who's Buying or Selling Takeda Pharmaceutical Co Ltd (HAM:TKDA) Stock Today? - gurufocus.com

Mar 29, 2026

Mar 29, 2026

Takeda Pharmaceutical Co Ltd Stock Intrinsic Values | HAM:TKDA - GuruFocus

Mar 29, 2026

Mar 29, 2026

Takeda Pharmaceutical Co Ltd Stock Historical Valuations | HAM:TKDA - GuruFocus

Mar 29, 2026

Mar 27, 2026

Takeda Pharmaceutical Co Ltd (LTS:0A87) Bonds - GuruFocus

Mar 27, 2026

Mar 25, 2026

Takeda Pharmaceutical (ADR) stock faces pressure amid pipeline setbacks and competitive oncology cha - AD HOC NEWS

Mar 25, 2026

Mar 23, 2026

What's Going On With Eli Lilly On Monday? - Benzinga

Mar 23, 2026

Mar 14, 2026

Takeda Pharmaceutical (ADR) Stock Steady Amid Pharma Sector Volatility as Investors Eye Pipeline Pro - AD HOC NEWS

Mar 14, 2026

Mar 13, 2026

Takeda Pharmaceutical Co Ltd (HAM:TKDA)Valuation Measures & Financial Statistics - GuruFocus

Mar 13, 2026

Mar 08, 2026

FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment - Finviz

Mar 08, 2026

Feb 27, 2026

DNLI Q4 Loss Narrower Than Expected, Hunter Syndrome Drug in Focus - Finviz

Feb 27, 2026

Feb 22, 2026

Takeda Stock: Quiet Japan Pharma With a Big U.S. Pipeline Bet - AD HOC NEWS

Feb 22, 2026

Feb 21, 2026

Takeda Stock: Quiet Pharma Giant That US Investors Keep Missing - AD HOC NEWS

Feb 21, 2026

Feb 19, 2026

Takeda Pharmaceutical ADR sees IBD RS rating climb to 76 - MSN

Feb 19, 2026

Feb 18, 2026

Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings? - Finviz

Feb 18, 2026

Feb 03, 2026

FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace

Feb 03, 2026

Feb 03, 2026

Earnings call transcript: Takeda beats Q3 2025 forecasts, stock climbs - Investing.com

Feb 03, 2026

Feb 02, 2026

Takeda Pharmaceutical ADR: Defensive Pharma Giant Tests Investor Patience as Shares Drift Near Lows - AD HOC NEWS

Feb 02, 2026

Jan 31, 2026

Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026? - Finviz

Jan 31, 2026

Jan 31, 2026

Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone - Yahoo Finance

Jan 31, 2026

Jan 30, 2026

Takeda Pharma ADR earnings beat by $0.04, revenue topped estimates - Investing.com Australia

Jan 30, 2026

Jan 30, 2026

Stocks To Watch: Takeda Pharmaceutical ADR Sees Relative Strength Rating Rise To 83 - Investor's Business Daily

Jan 30, 2026

Jan 29, 2026

Takeda Q3 FY2025 slides: Revenue dips 3.3% as company preps key 2026 launches - Investing.com

Jan 29, 2026

Jan 29, 2026

Earnings call transcript: Takeda Pharma Q3 2026 sees mixed performance - Investing.com

Jan 29, 2026

Jan 28, 2026

Apple, Visa, KLA-Tencor and more set to report earnings Thursday By Investing.com - Investing.com Nigeria

Jan 28, 2026

Jan 26, 2026

Takeda Pharmaceutical ADR Gets Technical Rating Upgrade - Investor's Business Daily

Jan 26, 2026

Jan 25, 2026

Biotech Stocks To Watch And Pharma Industry News - Investor's Business Daily

Jan 25, 2026

Jan 23, 2026

US earnings seasonQ4 2025 - Interactive Investor

Jan 23, 2026

Jan 22, 2026

ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz

Jan 22, 2026

Jan 15, 2026

KROS Stock Surges 85.6% in a Year: More Upside Potential in 2026? - Finviz

Jan 15, 2026

Jan 09, 2026

Takeda Pharmaceutical ADR Sees IBD RS Rating Climb To 76 - Investor's Business Daily

Jan 09, 2026